Spinal muscular atrophy (SMA) is a progressive, neuromuscular genetic disease that affects motor nerve cells in the spinal cord and is a leading cause of infant mortality. 1
Although conventional screening for SMA typically determines total SMN1 copy number, it does not include any information about how those copies are arranged, which limits the ability to identify silent carriers.
Quest SMA screening does more to minimize uncertainty